As of December 2024 Dermapharm has a market cap of $2.14 Billion USD. This makes Dermapharm the world's 4160th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.